Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

NCT05679024 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1400

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chronic Kidney Diseases
Atrial Fibrillation
Stroke
Intracerebral Hemorrhage
Major Bleed
Cardiovascular Complication
Death
Kidney Transplant; Complications
Thromboses, Venous

Interventions

DRUG: Apixaban 2.5 milligram Oral Tablet

Sponsor

Region Stockholm